Trial Profile
Pharmacokinetics of Levodopa After Repeated Doses of Carbidopa, ODM-104 and Levodopa: an Open, Randomised Study With Crossover Design in Healthy Males and Females
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Carbidopa (Primary) ; Levodopa (Primary) ; ODM 104 (Primary) ; Levodopa/carbidopa/entacapone
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Acronyms NOCOFPK2
- Sponsors Orion
- 19 Jun 2018 Results presented at the 4th Congress of the European Academy of Neurology
- 13 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Sep 2015 New trial record